"Six-and-Twelve" Prognostic Score in Transarterial Chemoembolization-Treated Hepatocellular Carcinoma Patients.

Objective: This study aimed to evaluate the overall survival of hepatocellular carcinoma patients who qualify for transarterial chemoembolization (TACE) using the "six-and-twelve" prognostic score. The research was conducted on a patient cohort between 2009 and 2019.

Materials And Methods: A retrospective cohort study was conducted, involving patients diagnosed with unresectable hepatocarcinoma, BarcelonaClinic Liver Cancer (BCLC) staging A or B, and Child-Pugh staging A or B.